The role of the triglyceride-glucose index as a biomarker of cardio-metabolic syndromes
Abstract Background The Triglyceride-glucose (TyG) index represents a simple, cost-effective, and valid proxy for insulin resistance. This surrogate marker has also been proposed as a predictor of metabolic and cardiovascular disease (CVD). In this descriptive review, we aimed to assess the utility...
Saved in:
| Main Authors: | Verena Gounden, Sridevi Devaraj, Ishwarlal Jialal |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-12-01
|
| Series: | Lipids in Health and Disease |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12944-024-02412-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The impact of the triglyceride-glucose index on the deterioration of kidney function in patients with cardiovascular-kidney-metabolic syndrome: insight from a large cohort study in China
by: Zhi Shang, et al.
Published: (2025-12-01) -
Elevated triglyceride glucose index is associated with advanced cardiovascular kidney metabolic syndrome
by: Lanlan Wu, et al.
Published: (2024-12-01) -
The Impact of Triglyceride-Glucose (TyG) Index on Future Cardio and Cerebrovascular Events in Patients with Acute Coronary Syndrome, During 3 Years of Follow-Up
by: Francesca Macaione, et al.
Published: (2024-11-01) -
Association between triglyceride-glucose index and cardiovascular disease in US adults with chronic kidney disease: a population-based study
by: Lijia Liu, et al.
Published: (2024-12-01) -
Combined effect of triglyceride-glucose index and atherogenic index of plasma on cardiovascular disease: a national cohort study
by: Qingyue Zeng, et al.
Published: (2024-12-01)